Two senators introduced legislation this month aimed at the part of antibiotic development that is hardest to fix with money alone: running the clinical trials that prove a new drug works against infections that are already life-threatening.
The Stop Superbugs Act, introduced Aug. 4 by Senator Maggie Hassan of New Hampshire and Senator Roger Marshall of Kansas, would require the director of the National Institute of Allergy and Infectious Diseases to award a competitive grant supporting a clinical research network on antibiotic resistance. It was read twice and referred to the Senate Health, Education, Labor and Pensions Committee.
